PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
PDS Biotech will host a virtual key opinion leader event on October 15, 2026, at 8:00 AM ET featuring Dr. Jonathan M. Hernandez of the National Cancer Institute. The event will discuss clinical outcomes from PDS0301 Phase 2 trials in advanced liver-associated cancers, focusing on the metastatic colorectal cancer cohort with liver metastases in second and third line MSS/pMMR patients.
Key figures
- Drug Name
- PDS0301
- Phase Of Trial
- Phase 2
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.